The UK's AI Security Institute published an evaluation on 26 October 2026 testing whether AI coding agents can rebuild biological AI tools from published descriptions alone. For two of the three tools tested, selected functions were reproduced at or near the original's performance, at a compute cost of between $4 and $20.
The evaluation is called ReproBAIT, for Reproducing Biological AI Tools. The Institute says it built it with SecureBio, a biosecurity research group. The finding matters to anyone relying on managed access — withholding a tool's code and releasing it only to vetted users — as a safeguard.
Each attempt ran in an isolated sandbox with a single GPU and no internet access. The agent received training data, a fixed time and compute budget, and a limited description of the original tool, then wrote and ran code to produce a working replica. A separate, network-isolated scorer compared the replica's performance with the original's on held-out data the agent had not seen.
Three instruments were targeted. ProteinMPNN and RFdiffusion3 are open-source protein design tools of increasing complexity; the third, described as CMD 1, is a closed-source molecular design tool whose code has never been released. Agents ran in two information conditions — abstract only, and the full paper with supplementary material — plus a with-code baseline for the two open tools. Four coding agents were used: Claude Opus 5, GPT-5.6 Sol, Kimi K3 and Qwen3.8-2.4T. Each configuration ran three times and the best attempt was reported.
On CMD, scored on the proportion of generated molecules that are chemically valid, all four agents closely matched or exceeded the original. The Institute notes the metric was already close to saturation, leaving little room for improvement, and that agents optimised a single metric at a modest cost to the novelty of the molecules produced.
On ProteinMPNN, scored on how often the tool picks the amino acid that occurs in nature at each position of a known protein backbone, the strongest agents approached the original. Claude Opus 5 reached 96.5 percent fidelity given the full paper; results varied across agents.
On RFdiffusion3, the most complex tool, no agent produced a successful reproduction within its time budget. One partially successful agent narrowed the task by filtering training data to easier structures, and further runs were excluded for returning near-duplicates of known Protein Data Bank entries.
Successful rebuilds of the two less complex tools typically cost between $4 and $20. No RFdiffusion3 rebuild succeeded, but each attempt cost between $102 and $301. Giving agents the full paper rather than the abstract alone did not consistently improve performance. One contributing factor the Institute raises is memorisation: the open tools' papers and code were very likely in the agents' pretraining data. Its diagnostics found moderate evidence consistent with memorisation for ProteinMPNN and little for RFdiffusion3, which it treats as a directional signal rather than proof.
The Institute's conclusion is scoped: selected functions of each tool can be reproduced with limited time and compute, but that does not prove the originals can be reproduced in full. It states that “withholding code or limiting the information published on a BAIT does not by itself equate to a safe release”, and that “controlling access to the underpinning biological data appears to be a more promising intervention than merely controlling access to code.”
The full paper carries a preprint date of 14 October 2026; the Institute published the blog post and research summary on 26 October 2026. The Institute sits within the Department for Science, Innovation and Technology.